Beacon Capital Management, LLC Bristol Myers Squibb CO Transaction History
Beacon Capital Management, LLC
- $540 Million
- Q2 2024
A detailed history of Beacon Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beacon Capital Management, LLC holds 2,644 shares of BMY stock, worth $129,899. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,644
Previous 2,690
1.71%
Holding current value
$129,899
Previous $145,000
24.83%
% of portfolio
0.02%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.17 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.79 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.49 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.67 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.9 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...